Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein

Clinical and Vaccine Immunology

Volumn 19, Issue 1, 2012, Pages 73-78

  Liu, Lidong ^a,b   Wen, Kun ^a,b   Li, Jie ^a,b   Hu, Dongmei ^a,b   Huang, Yanfen ^a,b   Qiu, Liwen ^a,b   Cai, Jianpiao ^a,b   Che, Xiaoyan ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HIGH THROUGHPUT SCREENING; IC 50; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SENSITIVITY AND SPECIFICITY; SEROTYPE; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; ENZYME-LINKED IMMUNOSPOT ASSAY; INHIBITORY CONCENTRATION 50; NEUTRALIZATION TESTS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL PLAQUE ASSAY;

EID: 84862953358     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05388-11     Document Type: Article

References (19)

1. Cai JP, et al. 2010. Characterization and secreted expression of dengue virus type I-IV envelope glycoprotein domain III in Pichia pastoris. Zhonghua Yu Fang Yi Xue Za Zhi 44:721-725. (In Chinese.)
2. Che XY, et al. 2004. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory symdrome. J. Clin. Microbiol. 42:2629-2635.
3. Ding X, et al. 2011. Full serotype- and group-specific NS1 capture enzyme-linked immunosorbent assay for rapid differential diagnosis of dengue virus infection. Clin. Vaccine Immunol. 18:430-434.
4. George R, Lum LCS. 1997. Clinical spectrum of dengue infection, p 89-114. In Gubler DJ and Kuno G (ed), Dengue and dengue hemorrhagic fever, 3rd ed. CAB International Press, London, United Kingdom.
5. Halstead SB. 2002. Dengue hemorrhagic fever: two infections and antibody dependent enhancement, a brief history and personal memoir. Rev. Cuba. Med. Trop. 54:171-179.
6. Halstead SB. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481. (Pubitemid 18084309)
7. Jin X, Block OT, Rose R, Schlesinger J. 2009. Dengue vaccine development and dengue viral neutralization and enhancement assays. Antivir. Ther. 14:739-749.
8. Jirakanjanakit N, Sanohsomneing T, Yoksan S, Bhamarapravati N. 1997. The micro-focus reduction neutralization test for determining dengue and Japanese encephalitis neutralizing antibodies in volunteers vaccinated against dengue. Trans. R. Soc. Trop. Med. Hyg. 91:614-617. (Pubitemid 27478663)
9. Kraus AA, Messer W, Haymore LB, de Silva AM. 2007. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45:3777-3780. (Pubitemid 350156883)
10. Lambeth CR, White LJ, Johnston RE, de Silva AM. 2005. Flow cytometry-based assay for titrating dengue virus. J. Clin. Microbiol. 43:3267-3272. (Pubitemid 40981334)
11. Lindenbach BD, Thiel HJ, Rice CM. 2007. Flaviviridae: the viruses and their replication, p 1103-1113. In Knipe DM and Howley PM (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
12. Martin NC, et al. 2006. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies. J. Virol. Methods 134:74-85.
13. Murphy BR, Whitehead SS. 2011. Immune response to dengue virus and prospects for a vaccine. Annu. Rev. Immunol. 29:587-619.
14. Russell PK, Nisalak A. 1967. Dengue virus identification by the plaque reduction neutralization test. J. Immunol. 99:291-296.
15. Shanaka WW et al. 2009. An automated Dengue virus microneutralization plaque assay performed in human Fcγ receptor-expressing CV-1 cells. Am. J. Trop. Med. Hyg. 80:61-65.
16. Thomas SJ, et al. 2009. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance. Am. J. Trop. Med. Hyg. 81:825-833.
17. Vorndam V, Beltran M. 2002. Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses. Am. J. Trop. Med. Hyg. 66:208-212. (Pubitemid 34755655)
18. Whitehead SS, Blaney JE, Durbin AP, Murphy BR. 2007. Prospects for a dengue virus vaccine. Nature reviews. Microbiology 5:518-528. (Pubitemid 46925380)
19. World Health Organization Department of Immunization Vaccines Biologicals. 2007. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. World Health Organization, Geneva, Switzerland. WHO/IVB/07.07. http://whqlibdoc.who.int/hq/2007/who-ivb-07.07-eng. pdf.